Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery.

about

Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery.

Item

http://www.wikidata.org/entity/Q38952976

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cell lines expressing recombin ...... s as tools for drug discovery.

@en

type

Item

label

Cell lines expressing recombin ...... s as tools for drug discovery.

@en

prefLabel

Cell lines expressing recombin ...... s as tools for drug discovery.

@en

P1476

Cell lines expressing recombin ...... es as tools for drug discovery

@en

P2093

Alexandra Ortiz

http://www.w3.org/2001/XMLSchema#string

Christoph Schaechtele

http://www.w3.org/2001/XMLSchema#string

Constance Ketterer

http://www.w3.org/2001/XMLSchema#string

Daniel Feger

http://www.w3.org/2001/XMLSchema#string

Daniel Müller

http://www.w3.org/2001/XMLSchema#string

Frank Totzke

http://www.w3.org/2001/XMLSchema#string

Holger Weber

http://www.w3.org/2001/XMLSchema#string

Jan Erik Ehlert

http://www.w3.org/2001/XMLSchema#string

Marianne Birkle

http://www.w3.org/2001/XMLSchema#string

Melanie Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

The ErbB/HER family of protein-tyrosine kinases and cancer

Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

Activation of the JNK pathway is essential for transformation by the Met oncogene

Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates.

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.

Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.

P304

1350-1361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087057114552414

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kurt Ballmer-Hofer

P577

2014-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266209703

http://www.w3.org/2001/XMLSchema#string

P698

25260782

http://www.w3.org/2001/XMLSchema#string

P921

transmembrane protein